chemistry, manufacturing, and controls (cmc) for an ind (7of14) redi 2018
Published 4 years ago • 27K plays • Length 1:19:35Download video MP4
Download video MP3
Similar videos
-
27:10
overview of post-approval chemistry, manufacture, and controls (cmc) changes to an nda - redi 2020
-
1:20:20
chemistry, manufacturing controls (cmc) in an investigational new drug (ind) (7/14) redi 2017
-
2:12
chemistry, manufacturing and controls (cmc)
-
34:37
lifecycle changes to chemistry, manufacture, and controls in ndas - redi 2020
-
32:21
good manufacturing practices (gmps) from an ind perspective (11of14) redi 2018
-
44:32
walkthrough of a pre-approval manufacturing site inspection (14of14) redi 2018
-
1:02:19
chemistry and manufacturing requirements for early clinical development: what’s in there? prove it.
-
10:08
(review) review of chemistry, manufacturing and control (cmc)- pmda-atc e-learning
-
33:18
investigational new drug (ind) submission: content/format and first 30 days (5of14) redi 2018
-
29:42
cmc considerations for car t cell product development
-
28:11
post-approval considerations for changes to manufacturing process and facilities - redi 2020
-
20:33
ich m7(r1) – chemistry and manufacturing control (cmc) perspective on hazard assessment
-
1:10:48
cmc - nda requirements and common pitfalls of blas (14of15) redi – may 29-30, 2019
-
46:00
introduction to investigational new drug (ind) applications (3/14) redi 2017
-
1:44
the chemical manufacturing & controls (cmc) function
-
25:14
regulatory applications of a nonclinical database for oligonucleotide therapeutics at u.s. fda
-
31:46
panel discussion – drug master file and drug substance workshop
-
44:31
nonclinical safety assessment for small molecules and biologic drug development (6of14) redi 2018